Prophylactic and/or therapeutic agent containing pyridylaminoacetic acid compound
AssigneeSanten Pharmaceutical Co., Ltd.
InventorsTomoko KIRIHARA, Atsushi SHIMAZAKI, Najam A. SHARIF
Life of this patent
Estimating the term…
Abstract
The object of the present invention is to find a new application of isopropyl (6-{ [4-(pyrazol-1-yl)benzyl] (pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate or a salt thereof. Isopropyl (6-{ [4-(pyrazol-1-yl)benzyl] (pyridin-3-ylsulfonyl) aminometh yl}pyridin-2-ylamino) acetate or a salt thereof is useful as a therapeutic agent for a disease involving a greatly elevated intraocular pressure.
Claims6
A method for preventing and/or treating a disease involving a greatly elevated intraocular pressure, comprising administering isopropyl (6-{ [4-(pyrazol-1-yl)benzyl] (pyridin-3-ylsulfonyl)aminometh yl}pyridin-2-ylamino) acetate or a salt thereof to patients with said disease which has to be prevented and/or treated, wherein the greatly elevated intraocular pressure is a disease with an intraocular pressure in a range from 25 to 100 mmHg.
Dependencies are inferred from the claim text.